<DOC>
	<DOCNO>NCT01013038</DOCNO>
	<brief_summary>In trial , investigator evaluate effect thrombus aspiration follow stent implantation improve myocardial blush grade patient acute non-ST-elevation myocardial infarction compare conventional percutaneous coronary intervention ( PCI ) .</brief_summary>
	<brief_title>Thrombus Aspiration During Percutaneous Coronary Intervention Acute Non-ST-elevation Myocardial Infarction Study</brief_title>
	<detailed_description>The Thrombus Aspiration Percutaneous coronary intervention Acute myocardial infarction Study ( TAPAS ) show thrombus aspiration improve myocardial perfusion clinical outcome compare conventional primary percutaneous coronary intervention ( PCI ) patient ST-segment elevation myocardial infarction . Impaired myocardial perfusion due spontaneous angioplasty-induced embolization atherothrombotic material also occur patient Non-ST-elevation myocardial infarction ( NSTEMI ) . The aim study determine whether thrombus aspiration stent implantation result improve myocardial perfusion patient NSTEMI compare conventional PCI . The study single-centre , prospective , randomised trial blind evaluation endpoint . The planned inclusion 540 patient acute NSTEMI candidate urgent PCI . If thrombus aspiration lead significant improvement myocardial perfusion patient acute NSTEMI may become part standard interventional approach .</detailed_description>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Thrombosis</mesh_term>
	<criteria>Diagnosis acute NSTEMI define Chest pain suggestive myocardial ischemia least 30 minute , Time onset symptoms less 72 hour ECG STsegment shift ( depression &gt; 0.1 mV least two contiguous lead transient STsegment elevation &gt; 0.1 mV least two contiguous lead le 30 minute ) and/or Twave change ( inversion &gt; 0.15 mV least two contiguous lead ) Positive cardiac troponin T &gt; 0,01 Î¼g/L . Clinical indication urgent PCI ischemiarelated target lesion identify coronary angiography Persistent STelevation 0.1 mV 2 lead Presence cardiogenic shock Inability obtain informed consent Known existence lifethreatening disease life expectancy le 6 month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2009</verification_date>
	<keyword>myocardial infarction</keyword>
	<keyword>percutaneous coronary intervention</keyword>
	<keyword>thrombus aspiration</keyword>
</DOC>